🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseSurvodutide SYNCHRONIZE Phase 3 — November 2025 Page 5

Survodutide SYNCHRONIZE Phase 3 — November 2025

ZaraB_AL Thu, Sep 12, 2024 at 4:18 AM 56 replies 2,243 viewsPage 5 of 12
mark_tokyo
Member
456
1,890
Jun 2024
Tokyo, JP
Oct 1, 2024 at 9:19 PM#21
anders_CPH said:
The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the…

Thank you for spelling out the reasoning rather than just the conclusion. Printing the relevant bit and taking it with me.

35 8pete_manc_UK, anna.melb_AU, mark_tokyo and 32 others
Reply Quote Save Share Report
PedsEndoPhilly
Member
345
1,890
Jun 2024
Philadelphia, PA
Oct 8, 2024 at 10:36 PM#22

From the other side of the consultation, briefly. The mechanism and the magnitude are separate questions. Agreeing that something happens says nothing about whether it happens enough to act on.

36 9wendy_avl, jason_paloalto, Dr.LeslieOBGYN and 33 others
Reply Quote Save Share Report
jennifer_SEA
Member
234
890
Nov 2024
Seattle, WA
Oct 15, 2024 at 11:49 PM#23
PedsEndoPhilly said:
The mechanism and the magnitude are separate questions.

Can confirm. Same sequence, different timescale. Nothing to add that would improve it.

37 10matt_MKE, Dr.ReproEndo, lucas_SP_BR and 34 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
InsuranceTom
Senior Member
1,345
7,890
Mar 2024
Connecticut
Oct 23, 2024 at 12:58 AM#24
PedsEndoPhilly said:
The mechanism and the magnitude are separate questions.

Coming at PedsEndoPhilly’s question from a different direction. It helps to say which part of this you are uncertain about. A precise question gets a precise answer; a general one gets everybody’s favourite anecdote.

Last edited: Oct 23, 2024 at 5:58 AM
38 11matt_MKE, Dr.ReproEndo, lucas_SP_BR and 35 others
Reply Quote Save Share Report
DataDave
Senior Member
1,678
8,901
Apr 2024
Washington
Online
Oct 30, 2024 at 2:03 AM#25

One concrete data point for the thread. If you are going to change something, change one thing and give it long enough to express itself. Four weeks is the usual minimum for anything pharmacological on this board, and two weeks of data has told you almost nothing.

Last edited: Oct 30, 2024 at 3:03 AM
39 12Dr.GutHealth, amsterdam_pete, LondonLisa and 36 others
Reply Quote Save Share Report
13456712

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register